The Division of Pediatric Hematology/Oncology has research programs at all three levels of research: clinical, translational and basic science. Special areas of basic science research include research on leukemia cell signaling, mechanisms of brain tumor development and mechanisms of cell death pathways.
Special clinical areas of research interest include, but are not limited to:
- Sarcoma clinical trials
- Comprehensive brain tumor clinic
- Novel conditioning regimens for stem cell transplantation
- Novel ways of decreasing inhibitor levels in patients with hemophilia
- Proton Beam Therapy Program (facility anticipated to open in 2015)
We are members of the Children's Oncology Group, the only cooperative group in the U.S. for childhood cancer. Ninety percent of our eligible patients are entered into available clinical trials. We also have access to a variety of new drugs to treat recurrent tumors.
Our goal is ultimately to be able to bring even more of "the bench to the bedside" as we strive to improve the cure rate of childhood cancer.